What is the proper use and dosage of Ivermectin (antiparasitic medication)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ivermectin: Proper Use and Dosing for Parasitic Infections

Ivermectin is dosed at 200 mcg/kg orally for most parasitic infections, with a mandatory second dose 14 days later for scabies and pediculosis due to limited ovicidal activity, and must be taken with food to maximize bioavailability and drug penetration into tissues. 1, 2

Standard Dosing by Indication

Scabies

  • 200 mcg/kg orally as a single dose, repeated in exactly 14 days 1, 2
  • The second dose is mandatory, not optional—ivermectin has limited ovicidal activity and will not kill eggs present at initial treatment 1
  • For a 56-kg patient, this equals four 3-mg tablets (12 mg total) per dose 2

Pediculosis Pubis (Pubic Lice)

  • 250 mcg/kg orally, repeated in 14 days 1, 2
  • Higher dose than scabies due to different parasite biology 1

Strongyloidiasis

  • 200 mcg/kg as a single oral dose 3, 4
  • Additional doses generally not necessary, but follow-up stool examinations required to verify eradication 3
  • Ivermectin achieves significantly higher cure rates than albendazole (RR 1.79,95% CI 1.55-2.08) 4

Onchocerciasis

  • 150 mcg/kg as a single oral dose 3
  • Retreatment intervals: 12 months for mass campaigns, as short as 3 months for individual patients 3

Crusted (Norwegian) Scabies

  • 200 mcg/kg on days 1,2,8,9, and 15 1
  • Must be combined with daily topical permethrin 5% or benzyl benzoate 5% for 7 days, then twice weekly 1
  • Additional doses on days 22 and 29 may be required for severe cases 1
  • This aggressive regimen is necessary because single-dose therapy has substantial failure rates in immunocompromised patients 1

Critical Administration Guidelines

Food Requirements

  • Take ivermectin WITH FOOD for scabies, pediculosis, and most parasitic infections to increase bioavailability and enhance drug penetration into the epidermis 1, 2
  • Take ivermectin on an EMPTY STOMACH for strongyloidiasis and onchocerciasis per FDA labeling 3
  • This distinction is crucial—the food requirement varies by indication 2, 3

Special Population Considerations

Pediatric Patients

  • Do not use in children weighing <15 kg—safety has not been established 1, 2
  • For children <10 years with scabies, use permethrin instead of ivermectin 1, 2

Pregnancy and Lactation

  • Classified as "human data suggest low risk" in pregnancy and probably compatible with breastfeeding 2

Renal Impairment

  • No dose adjustments required 1, 2

Hepatic Impairment

  • Use with extreme caution in severe liver disease—safety of multiple doses is not established 1, 5, 2
  • Patients with severe liver disease may be at higher risk for toxicity 5

Common Pitfalls to Avoid

Forgetting the Second Dose

  • The 14-day repeat dose for scabies and pediculosis is mandatory, not optional 1, 2
  • Failure to give the second dose will result in treatment failure as eggs hatch after initial treatment 1

Inadequate Contact Treatment

  • All household and sexual contacts within the previous month must be treated simultaneously for scabies and pediculosis 1, 2
  • Failure to treat contacts leads to reinfection and persistent symptoms 1

Misinterpreting Persistent Symptoms

  • Rash and pruritus may persist for up to 2 weeks after successful treatment due to allergic dermatitis 1, 2
  • This is NOT treatment failure—do not retreat unless live mites are observed or symptoms persist beyond 2 weeks 1

Environmental Decontamination

  • Machine-wash and dry bedding/clothing using hot cycle, or remove from body contact for 72 hours 1
  • Fumigation is unnecessary 1

Safety Profile

Adverse Events

  • Generally well-tolerated with no significant difference in adverse events compared to albendazole 4
  • Significantly fewer adverse events than thiabendazole (RR 0.31,95% CI 0.20-0.50) 4
  • Common side effects include dizziness, nausea, and disorientation 4
  • High-dose regimens (≥400 mcg/kg) show comparable safety to standard doses, though ocular events may increase in onchocerciasis patients 6
  • Adverse reactions decrease significantly with repeated dosing—severe reactions (9%) only occur after first dose 7

Contraindications

  • Do not use lindane as first-line therapy—ivermectin is safer and should be used preferentially 1
  • Lindane can cause seizures and aplastic anemia and should only be used when other therapies fail 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ivermectin Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ivermectin Toxicity Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Safety of high-dose ivermectin: a systematic review and meta-analysis.

The Journal of antimicrobial chemotherapy, 2020

Research

Decrease in adverse reactions after repeated ivermectin treatment in onchocerciasis.

Documenta ophthalmologica. Advances in ophthalmology, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.